block 5 pharm

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/415

encourage image

There's no tags or description

Looks like no tags are added yet.

416 Terms

1
New cards

Prostaglandin E2

- produced by gastric mucosa,

- inhibits acid secretion and stimulates mucus and bicarbonate secretion = cytoprotective

- NSAIDs decrease the production

2
New cards

Cholinergic

Dicylcomine blocks ______________________ receptors

3
New cards

H2-Histamine

Cimetidine blocks the ____________________ receptor

4
New cards

Prostaglandin

Misoprostol stimulates the ___________________ receptor

5
New cards

-Proton pump inhibitors

-Histatmine H2-receptor antagonists

-Antacids

-Anti-refluxants

main categories of acid suppressants

6
New cards

• Weight loss

• Elevation of the head end of the bed and avoidance of food 2-3 hrs before bedtime

-Avoid foods that can cause irritation of mucosa

• Avoid alcohol consumption and no smoking.

lifestyle modifications for GERD

7
New cards

• LNf (Laparoscopic Nissen fundoplication)

• Bariatric surgery (in obese patients)

anti-reflux surgeries

8
New cards

OTC antacids, H2-receptor antagonists or [PPIs for 2 weeks QD]

how do pts typically self treat for mild GERD

9
New cards

increasing

Pharmacologic treatment for GERD typically involve ___________________ the pH of gastric contents

10
New cards

Alarm symptoms

Recurring symptoms after 2 weeks of lifestyle modification/self treatment

Prescription strength H2RAs or (PPIs for 8 weeks QD) + maintenance therapy if symptoms recur

when are prescriptions for GERD indicated?

11
New cards

Proton pump inhibitors (PPI's)

provide the greatest symptom relief and the highest healing rates for GERD, especially for patients with erosive disease or moderate-to-severe symptoms or with complications.

12
New cards

8-12 weeks of twice-daily PPI therapy

treatment for Patients with erosive esophagitis on endoscopy

13
New cards

Proton pump inhibitors (PPI's)

the drug of choice for maintenance of patients with moderate-to-severe GERD

14
New cards

Antacids

acid neutralizers

15
New cards

-Histamine H2-Receptor Antagonists

-Proton pump inhibitors (PPI's)

acid reducers

aka antisecretory agents

16
New cards

-Calcium carbonate

-Magnesium

-Magnesium-Aluminum-Simethicone

-Sodium Bicarbonate

-Antacid + Alginic Acid

Antacids

17
New cards

Antacids

• Mechanism: neutralize gastric acid → ↑ gastric pH

• Fast acting (w/in minutes) & short duration (30-60 min)

• Most suitable for mild, infrequent symptoms

18
New cards

• Unpleasant taste

• Electrolyte disturbances

adverse effects for antacids

19
New cards

constipation or loss stools

AEs for antacid: calcium carbonate

20
New cards

Constipation

AEs for antacid: aluminum

21
New cards

Loss stools, Diarrhea

AEs for antacid: magnesium

22
New cards

-Gastric distension

-belching

-metabolis alkalosis

AEs for antacid: sodium bicarbonate and calcium carbonate

23
New cards

Antacids

GERD medication that is a safer choice for pregnancy

24
New cards

• Tetracyclines

• Fluoroquinolones

• Itraconazole

• Iron

Antacids should not be taken within 2 hours of ______________________________________

25
New cards

• Famotidine

• Ranitidine

• Nizatidine

• Cimetidine

Histamine-2 receptor antagonists (H2RAs)

26
New cards

Histamine-2 receptor antagonists (H2RAs)

Indications:

• GERD

• PUD

• Dyspepsia/indigestion (non-ulcer)

• Stress ulcer prophylaxis

• Critically ill patients (ICU)

27
New cards

Histamine-2 receptor antagonists (H2RAs)

-reversibly inhibit H2 receptors on gastric parietal cells

-decrease gastric acid secretion

-increase gastric acid pH

-highly selective and last 4-10 hours

• IV admin in critically ill

28
New cards

Cimetidine

may cause gynecomastia or impotence in men & galactorrhea in women with long-term use

Can cause Vitamin B12 deficiency

29
New cards

Histamine-2 receptor antagonists (H2RAs)

• Diarrhea or constipation

• Headache

• Fatigue

• Myalgias

-increased risk for pneumonia

-mental status changes

30
New cards

Histamine-2 receptor antagonists (H2RAs)

• ↓ absorption of drugs requiring low stomach pH for dissolution

• May have additive effects with CNS depressants

• May inhibit gastric first-pass metabolism of ethanol

• Antacids reduces the absorption

31
New cards

Proton pump inhibitors (PPI's)

-irreversibly binds and inactivates active H+/K+ ATPase pumps in parietal cells

-blocks acid secretion

32
New cards

Proton pump inhibitors (PPI's)

-take on an empty stomach 1 hour before meal

-duration is 24 hours

-all are prodrugs

-It takes 3-4 days of daily dosing for full acid-inhibition.

• >90% duodenal ulcers healed w/in 4 wks

• >90% gastric ulcers healed w/in 8 wks

33
New cards

• *Omeprazole

• *Esomeprazole

• *Lansoprazole

• Dexlansoprazole

• Rabeprazole

• Pantoprazole

Proton pump inhibitors (PPI's)

34
New cards

Proton pump inhibitors (PPI's)

Indications:

• GERD

• PUD

• A drug of choice for maintenance therapy in GERD

• Non-ulcer dyspepsia (benefit 10-20% of pts. above placebo)

• Erosive esophagitis

• Esophageal stricture

• Gastric hypersecretions (e.g., gastrinoma)

• Stress ulcer prophylaxis (critically ill patients)

35
New cards

Proton pump inhibitors (PPI's)

AEs:

-C. diff infection

-pneumonia

-fractures of hip, wrist, and spine

-gastric acid rebound or reflux symptoms

-iron deficiency anemia

36
New cards

• Calcium citrate

• B12 via intranasal or IM route

• Iron via IV route

if needed, what supplementation can you give with Proton pump inhibitors (PPI's)

37
New cards

• Helicobacter pylori

• Chronic NSAIDs (including aspirin)

• Acid hypersecretion

common causes of PUD

38
New cards

Bismuth Quadruple Therapy:

-Bismuth + metronidazole + tetracycline + PPI

Concomitant Quadruple Therapy:

-Clarithromycin + amoxicillin + metronidazole + PPI

Triple Therapy:

-Clarithromycin + Metronidazole + PPI

or

-Clarithromycin + amoxicillin + PPI

Preferred treatment regimen for H. pylori induced ulcer

39
New cards

• Discontinue NSAID, (may give sucralfate)

• Initiate H2RA or PPI

treatment for NSAID-associated ulcers

40
New cards

PPI to promote ulcer healing

treatment for NSAID-associated ulcers if NSAID cannot be discontinued

41
New cards

-Metronidazole

-Tetracycline

-Clarithromycin

-Amoxicillin

Abx used to erradicate H. pylori in PUD

42
New cards

Metronidazole

-Metabolized by bacteria into reduced reactive compounds

-damages bacterial DNA, proteins, and membranes to cause cell death

-anaerobic bacteria, protozoans, and H. pylori

43
New cards

Metronidazole

CIs:

-alcohol use within 3 days

-Use within 2 weeks of disulfiram

AEs:

-GI upset

-headache

44
New cards

Tetracycline

-Binds 30s ribosomal subunit

-inhibits attachment of aminoacyl-tRNA

-decreases protein synthesis

-for G+ and G- bacteria, some anaerobes, Rickettsia, Chlamydia, Mycoplasma

-H. pylori

45
New cards

Tetracycline

CIs:

-last half of pregnancy

-children

46
New cards

Clarithromycin

-binds 50s ribosomal subunit

-decreases peptide bond formation

-decreases protein synthesis

-G+ bacteria (not enterococci), intracellulars, atypicals, and H. pylori

47
New cards

Clarithromycin

AEs:

-motility (GI issues)

-Arrhythmias

-Cholestatic hepatitis

-rash

-eosinophilia

48
New cards

Amoxicillin

-Bind PBPs

-decreases peptidoglycan crosslinking

-decreases bacterial cell wall synthesis

-G+ bacteria, enhanced G- bacteria coverage, H. pylori

-often used with beta-lactamase inhibitor

49
New cards

Amoxicillin

AEs:

-rash

-GI upset (diarrhea)

-serious allergic rxn (Contraindication)

• May ↓ effectiveness of hormonal contraception.

50
New cards

-Sucralfate

-Misoprostol

-Bismuth Compounds

gastric mucosa protectants

51
New cards

Sucralfate

-forms viscous protective paste that binds selective ulcers and erosions

-may stimulate mucosal prostaglandin and bicarbonate secretion

-primarily excreted in feces

-administer on an empty stomach

52
New cards

Sucralfate

• Indication: Ulcer (duodenal, gastric, stress prophylaxis)

• Clinical use limited by H2RAs and PPIs

-AE: constipation

53
New cards

Misoprostol

-prodrug

-prostaglandin (PGE1) analog

-acid inhibitory and mucosal protective properties

• Admin' TID or QID

54
New cards

Misoprostol

Indications:

• Duodenal ulcer

• Prophylaxis of NSAID-induced ulcer (PPIs preferred)

• Adverse effects: GI upset (pain, nausea, diarrhea)

• Contraindications: pregnancy, childbearing potential

55
New cards

Bismuth compounds

• Coats ulcers & erosions, protects against acid & pepsin

• Direct antimicrobial (H. pylori) effects; binds enterotoxins

• May stimulate prostaglandin, mucus, and bicarbonate secretion

56
New cards

Bismuth compounds

Indications

• Dyspepsia, indigestion

• Acute diarrhea, upset stomach

• H pylori GI infection

57
New cards

Bismuth Subsalicylate

Contraindications

• Salicylate allergy

• Child/teenager recovering from viral infection (e.g., chicken pox, flu) — risk of Reye's Syndrome

• Nursing

• Pregnancy >20 weeks

Adverse effects

• Dark tongue or stool (harmless) (bismuth)

• Salicylate toxicity (high dose/prolonged use)

58
New cards

-Bethanechol

-Metoclopramide

promotility agents

59
New cards

Bethanechol

• Stimulates M3 receptors on muscle cells and at myenteric plexus synapses

• Increases LES pressure in GERD

60
New cards

Bethanechol

Indication

• Urinary retention

• No longer used for GERD due to adverse effects + better agents available

AEs: GI upset, decreased BP with reflex tachycardia, urinary urgency

61
New cards

Metoclopramide

-Blocks dopamine (D2) receptors

-prevents inhibition of cholinergic smooth muscle stimulation

-increases esophageal peristaltic amplitude

-increases LES pressure and gastry emptying

-potential antinausea and antiemetic action in chemoreceptor trigger zone of medulla

62
New cards

Metoclopramide

Indications

• GERD (not effective in erosive esophagitis)

• Diabetic gastroparesis

• Nausea/vomiting (chemotherapy-induced, postoperative)

63
New cards

Metoclopramide

Adverse effects

• Drowsiness, insomnia, anxiety, agitation

• Dystonia, akathisia, parkinsonism

• Elevated prolactin levels → galactorrhea, gynecomastia, impotence, menstrual disorders

• Tardive dyskinesia (avoid long term use, if possible!)

Contraindications

• Epilepsy (↑ risk of seizures)

• GI hemorrhage, mechanical obstruction, or perforation

• Pheochromocytoma (↑ risk of hypertensive crisis)

64
New cards

• Sulfasalazine

• Olsalazine

• Balsalazide

• Mesalamine

5-Aminosalicylates (5-ASA)

65
New cards

•5-Aminosalicylates (5-ASA)

•Corticosteroids

•Immunosuppressives

• Janus kinase inhibitors

• S1P receptor modulator

• Biologics

Drug categories used to treat IBD

66
New cards

-Infliximab

-Adalimumab

-Golimumab

-Certolizumab

Anti-TNF biologics

67
New cards

-Vedolizumab

-Natalizumab

Anti-integrins (CAM inhibitors)

68
New cards

Ustekinumab

Interleukin (IL)-12/23 antagonist

69
New cards

Risankizumab

Interleukin-23 (IL-23) inhibitor

70
New cards

Tofacitinib

Janus kinase inhibitors

71
New cards

Ozanimod

S1P receptor modulator

72
New cards

Azathioprine and mercaptopurine

Thiopurines (immunosuppresive)

73
New cards

Mesalamine

formulated 5-aminosalicylic acid (5-ASA)

74
New cards

5-Aminosalicylates (5-ASA)

• Thought to work topically

-Activates the production of IL-1, TNF-alpha, and PPARy

-Inhibits lipoxygenase pathway and NFκ β

75
New cards

Mesalamine

-coated in a pH sensitive coating that dissolves at pH 6-7 to release in small intestine and colon

-suppository form is suspended in a wax matrix

-enema form

- Asacol, Apriso, Lialda, Delzicol, and Pentasa

76
New cards

Which ever formulation is relased at the location that is inflamed in the GI tract

How do you pick with 5-ASA to use?

77
New cards

5- Aminosalicylates (5-ASA)

• 1st line - induce/maintain remission in mild-moderate UC

• Not recommended for CD due to lack of efficacy but still widely used

78
New cards

5- Aminosalicylates (5-ASA)

Contraindications

• Hypersensitivity to salicylates (e.g., aspirin)

• Adolescent recovering from viral infection (↑ Reye's syndrome risk)

• Hypersensitivity to sulfonamides (sulfasalazine only)

AEs:

-headache

-dyspepsia

-skin rash

-rarely nephrotoxicity

79
New cards

Sulfasalazine (5-ASA)

AEs:

-headache, nausea, fatigue

-rash, fever, Stevens-Johnson syndrome , pneumonitis, hemolytic

anemia, myelosuppression

• Inhibits intestinal folate absorption- administer with folate

• Oligospermia (reversible)

80
New cards

Glucocorticoids (GCs)

• Anti-inflammatory & immunosuppressive actions

-decreases production and expression of: TNFα, IL-1, IL-8, inflammatory cell adhesion molecules, Phospholipase A2, Cyclooxygenase, and NF-kB

81
New cards

Glucocorticoids (GCs)

-bind to receptors and release Hsp90

-actiavted GCR binds to GREs on gene that result in expression of proteins that suppress immune response, inflammation

82
New cards

Prednisone

• Most common GC used for induction of remission in CD

• Converted to active moiety after 1st pass metabolism

• Intermediate duration of action → Qday dosing

• Most patients respond within 10-14 days and dose can be tapered

83
New cards

Methylprednisolone

which is preferred?

Methylprednisolone or hydrocortisone

84
New cards

Budesonide

-synthetic corticosteroid

-oral once daily, rectal, enema, and suppository forms

• Greater affinity (15x) for GC receptor

-low systemic bioavailability

-

85
New cards

Glucocorticoids (GCs)

-used to induce remission of IBD but not to maintain remission

-avoid long term use

• PO for moderate-severe active IBD

• Admin IV if severely ill

86
New cards

Budesonide

__________________________ PO controlled release useful in:

• Mild-moderate CD of ileum and proximal colon (Entocort®)

• Mild-moderate UC (Uceris®)

87
New cards

Oral Glucocroticoids (GCs)

Short-term systemic side effects

• insomnia, weight gain, emotional lability, GI upset, ↑ blood pressure and blood glucose

Long-term systemic use side effects

• cataracts, hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's, immunosuppression, osteoporosis, delayed growth in children, acne

88
New cards

• Azathioprine

• Mercaptopurine

Purine Analogs (immunosuppressives)

89
New cards

Purine Analogs

• Impairs purine biosynthesis and inhibit cellular proliferation of immune cell

• These are prodrugs that are metabolized to their active form:

90
New cards

Purine Analogs

Use -maintain remission (UC, CD)

• Mod-Severe IBD

• Steroid resistant / steroid dependent

• Used as an adjunct to glucocorticoids & biologics

• Treatment with TNFα inhibitors and Aza along with surgery is used for treatment of fistulizing Crohn's

91
New cards

Purine Analogs

• Delayed onset - 17 wks (average)

• ~50% achieve remission in 3-6 months; maintain remission in 80%

-monitor TPMT enzyme activity

-avoid in breast feedin

92
New cards

Purine Analogs

Adverse effects:

• GI upset (severe n/v/d)

• Bone marrow suppression leads to - ↓CBC count

• Hepatotoxicity

-increases risk of lymphoma, hematologic toxicities, and mutagenic potential

DIs:

-allopurinol, febuxostat, mesalamine, ACEis, Trimethoprim/sulfamethoxazole, Warfarin

93
New cards

Folic Acid Analog

(Methotrexate)

-immunosuppressive & anti-inflammatory

-Irreversibly inhibits dihydrofolate reductase

• ↓ thymidine & purine producon = interferes w/ DNA synthesis/repair

• May ↓ IL-1 & ↑ adenosine

• IM weekly

94
New cards

Folic Acid Analog

(Methotrexate)

• Use - Maintenance of CD remission

• off label as alternative to thiopurine to withdraw corticosteroid

• Delayed onset ~ 12 weeks

CIs:

• Pregnancy/breastfeeding

• Alcoholism

• Chronic liver disease

• HIV/AIDS

• Preexisting blood dyscrasias

95
New cards

Folic Acid Analog

(Methotrexate)

Adverse effects

• Bone marrow, liver, lung, skin, and kidney toxicities (monitor)

• Fetal death, congenital anomalies

• Folate (Vit B9) deficiency

• Supplement with folic acid or folinic acid

DIs:

• Live vaccines (↑ risk of infection)

• NSAIDs

96
New cards

TNFα Inhibitors

-immunosuppressive & anti-inflammatory

• Delayed onset - ~2 weeks

Use -induce/maintain remission

• G.I.A for UC

• C.I.A for CD

97
New cards

TNFα Inhibitors

Adverse effects:

• Infusion/injection reactions

• Serious infection

• Reactivation of TB

• Antibodies to the antibody

• Delayed serum-sickness-like reaction

98
New cards

CAM Inhibitors (aka Anti-integrins)

-Monoclonal antibody that binds to and inhibits the α4-integrin subunit.

-they block binding of α4β1 and α4β7 on lymphocytes to MADCAM 1 and prevent lymphocyte recruitment to the intestinal mucosa

99
New cards

Vedolizumab

-binds to α4ß7 integrins found on T-lymphocytes

-use: induction/maintenance of moderate-severe CD or UC

100
New cards

CAM Inhibitors (aka Anti-integrins)

• Admin IV over 30-60 min; DC if no response after 12-14 wks

-can be considered if failure to respond to corticosteroids or are intolerant TNFα inhibitor